<!DOCTYPE html>
<html lang="en" dir="ltr">
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>Cerebral Palsy Hub | CarePedia Information Center</title>
<link rel="preconnect" href="https://fonts.googleapis.com">
<link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
<link href="https://fonts.googleapis.com/css2?family=Rubik:wght@300;400;500;600;700;800;900&display=swap" rel="stylesheet">
<link rel="alternate" hreflang="he" href="https://carepedia.org/cerebral-palsy" />
<link rel="alternate" hreflang="en" href="https://carepedia.org/en/cerebral-palsy" />

<style>
* { margin: 0; padding: 0; box-sizing: border-box; }

:root {
  --primary: #0f4c75;
  --primary-light: #3282b8;
  --accent: #00b894;
  --accent-light: #55efc4;
  --warm: #fdcb6e;
  --warm-dark: #e17055;
  --bg: #f0f4f8;
  --card: #ffffff;
  --text: #2c3e50;
  --text-light: #5d6d7e;
  --shadow: 0 4px 20px rgba(0,0,0,0.08);
  --shadow-hover: 0 12px 40px rgba(0,0,0,0.18);
  --radius: 16px;
  --transition: all 0.3s cubic-bezier(.4,0,.2,1);
  /* Aliases for Iconify icons */
  --forest: #0f4c75;
  --forest-mid: #3282b8;
  --forest-light: rgba(50,130,184,0.12);
  --amber: #fdcb6e;
  --amber-light: rgba(253,203,110,0.12);
  --border: #dde4eb;
}

body {
  font-family: 'Rubik', 'Segoe UI', Tahoma, Arial, sans-serif;
  background: var(--bg);
  color: var(--text);
  line-height: 1.8;
  overflow-x: hidden;
  position: relative;
}

body::before {
  content: '';
  position: fixed;
  top: 0; left: 0; width: 100vw; height: 100vh;
  background:
    radial-gradient(ellipse at 10% 20%, rgba(15,76,117,0.07) 0%, transparent 50%),
    radial-gradient(ellipse at 90% 80%, rgba(0,184,148,0.07) 0%, transparent 50%),
    radial-gradient(ellipse at 50% 50%, rgba(253,203,110,0.05) 0%, transparent 60%);
  pointer-events: none;
  z-index: 0;
}

.scroll-progress {
  position: fixed;
  top: 0; right: 0;
  width: 100%; height: 4px;
  z-index: 2000;
  background: transparent;
}
.scroll-progress .bar {
  height: 100%; width: 0%;
  background: linear-gradient(90deg, var(--accent), var(--primary-light), var(--warm));
  border-radius: 0 0 0 4px;
  transition: width 0.1s linear;
}

.sidebar {
  position: fixed;
  top: 0; left: 0;
  width: 280px; height: 100vh;
  background: rgba(15,76,117,0.85);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border-right: 1px solid rgba(255,255,255,0.1);
  z-index: 1000;
  padding: 30px 20px;
  overflow-y: auto;
  transition: transform 0.4s cubic-bezier(.4,0,.2,1);
}
.sidebar .logo {
  text-align: center;
  margin-bottom: 30px;
  padding-bottom: 20px;
  border-bottom: 1px solid rgba(255,255,255,0.15);
}
.sidebar .logo .icon { font-size: 48px; }
.sidebar .logo h2 { color: #fff; font-size: 18px; margin-top: 8px; font-weight: 600; }
.sidebar nav a {
  display: flex; align-items: center; gap: 12px;
  padding: 14px 18px; color: rgba(255,255,255,0.8);
  text-decoration: none; border-radius: 12px;
  margin-bottom: 4px; font-size: 15px; transition: var(--transition);
}
.sidebar nav a:hover, .sidebar nav a.active {
  background: rgba(255,255,255,0.15); color: #fff; transform: translateX(4px);
}
.sidebar nav a .nav-icon { font-size: 22px; min-width: 30px; text-align: center; }

.menu-toggle {
  display: none;
  position: fixed;
  top: 20px; left: 20px;
  z-index: 1100;
  background: var(--primary); color: #fff;
  border: none; border-radius: 12px;
  width: 50px; height: 50px; font-size: 24px;
  cursor: pointer; box-shadow: var(--shadow); transition: var(--transition);
}
.menu-toggle:hover { transform: scale(1.05); }
.menu-toggle.open { border-radius: 50%; background: var(--warm-dark); }

.main {
  margin-left: 280px;
  min-height: 100vh;
  position: relative;
  z-index: 1;
}

.hero {
  background: linear-gradient(135deg, var(--primary) 0%, #3282b8 40%, var(--accent) 100%);
  padding: 80px 60px;
  color: #fff;
  position: relative;
  overflow: hidden;
}
.hero::before {
  content: '';
  position: absolute;
  top: -50%; left: -50%;
  width: 200%; height: 200%;
  background: radial-gradient(circle, rgba(255,255,255,0.05) 0%, transparent 60%);
  animation: float 20s linear infinite;
}
@keyframes float { 0% { transform: rotate(0deg); } 100% { transform: rotate(360deg); } }
.hero-content { position: relative; z-index: 1; max-width: 900px; }
.hero h1 { font-size: 52px; font-weight: 800; margin-bottom: 10px; line-height: 1.3; }
.hero .greeting { font-size: 22px; opacity: 0.95; margin-bottom: 30px; line-height: 1.7; }
.hero .subtitle { font-size: 18px; opacity: 0.8; max-width: 700px; }

.fade-in { opacity: 0; transform: translateY(30px); transition: opacity 0.7s ease, transform 0.7s ease; }
.fade-in.visible { opacity: 1; transform: translateY(0); }

.section { padding: 60px; max-width: 1100px; margin: 0 auto; }
.section-header {
  display: flex; align-items: center; gap: 16px;
  margin-bottom: 40px; padding-bottom: 20px;
  border-bottom: 3px solid var(--primary-light);
}
.section-header .sec-icon { font-size: 42px; }
.section-header h2 { font-size: 36px; color: var(--primary); }
.section-header p { color: var(--text-light); font-size: 16px; margin-top: 4px; }

.cards-grid {
  display: grid;
  grid-template-columns: repeat(auto-fill, minmax(300px, 1fr));
  gap: 24px; margin-bottom: 40px;
}
.card {
  background: var(--card); border-radius: var(--radius); padding: 30px;
  box-shadow: var(--shadow); transition: var(--transition);
  border-top: 4px solid var(--primary-light);
  position: relative; overflow: hidden;
}
.card:hover { transform: translateY(-6px) scale(1.01); box-shadow: var(--shadow-hover); }
.card .card-icon { font-size: 40px; margin-bottom: 16px; }
.card h3 { font-size: 20px; color: var(--primary); margin-bottom: 12px; }
.card p { color: var(--text-light); font-size: 15px; line-height: 1.8; }
.card.green { border-top-color: var(--accent); }
.card.orange { border-top-color: var(--warm); }
.card.blue { border-top-color: var(--primary-light); }

.cat-grid {
  display: grid;
  grid-template-columns: repeat(auto-fill, minmax(240px, 1fr));
  gap: 20px; margin-top: 40px;
}
.cat-card {
  background: var(--card); border-radius: var(--radius); padding: 30px 24px;
  text-align: center; cursor: pointer; transition: var(--transition);
  box-shadow: var(--shadow); text-decoration: none; color: var(--text);
}
.cat-card:hover { transform: translateY(-6px) scale(1.02); box-shadow: var(--shadow-hover); }
.cat-card .cat-icon { font-size: 48px; margin-bottom: 14px; }
.cat-card h3 { font-size: 18px; color: var(--primary); margin-bottom: 8px; }
.cat-card p { font-size: 13px; color: var(--text-light); }

.accordion { margin-bottom: 16px; }
.accordion-header {
  background: var(--card); padding: 20px 24px; border-radius: var(--radius);
  cursor: pointer; display: flex; justify-content: space-between; align-items: center;
  box-shadow: var(--shadow); transition: var(--transition);
  font-size: 17px; font-weight: 600; color: var(--primary);
}
.accordion-header:hover { background: #eef4fb; }
.accordion-header .arrow { transition: transform 0.3s ease; font-size: 20px; }
.accordion-header.open .arrow { transform: rotate(180deg); }
.accordion-body {
  max-height: 0; overflow: clip; transition: max-height 0.4s ease;
  background: var(--card); border-radius: 0 0 var(--radius) var(--radius); margin-top: -8px;
}
.accordion-body .inner { padding: 20px 24px 24px; color: var(--text-light); line-height: 2; }

.tabs { display: flex; gap: 8px; margin-bottom: 24px; flex-wrap: wrap; }
.tab-btn {
  padding: 12px 24px; background: var(--card);
  border: 2px solid #dde4eb; border-radius: 30px;
  cursor: pointer; font-size: 15px; font-family: inherit;
  color: var(--text-light); transition: var(--transition);
}
.tab-btn:hover { border-color: var(--primary-light); color: var(--primary); }
.tab-btn.active { background: var(--primary); color: #fff; border-color: var(--primary); }
.tab-content { display: none; animation: fadeIn 0.4s ease; }
.tab-content.active { display: block; }
@keyframes fadeIn { from { opacity: 0; transform: translateY(10px); } to { opacity: 1; transform: translateY(0); } }

.info-box {
  background: linear-gradient(135deg, #eaf4fb 0%, #e8f8f0 100%);
  border-radius: var(--radius); padding: 24px 28px; margin: 24px 0;
  border-left: 5px solid var(--primary-light);
}
.info-box.warning { background: linear-gradient(135deg, #fef9e7 0%, #fdebd0 100%); border-left-color: var(--warm); }
.info-box.success { background: linear-gradient(135deg, #e8f8f0 0%, #d5f5e3 100%); border-left-color: var(--accent); }
.info-box h4 { color: var(--primary); margin-bottom: 8px; font-size: 17px; }
.info-box p { color: var(--text-light); font-size: 15px; }

.link-btn {
  display: inline-flex; align-items: center; gap: 8px;
  padding: 12px 24px; background: var(--primary);
  color: #fff; text-decoration: none; border-radius: 30px;
  font-size: 15px; transition: var(--transition); margin: 6px;
}
.link-btn:hover { background: var(--primary-light); transform: translateY(-2px); }
.link-btn.green { background: var(--accent); }
.link-btn.green:hover { background: var(--accent-light); color: var(--text); }
.link-btn.orange { background: var(--warm-dark); }
.link-btn.orange:hover { background: var(--warm); color: var(--text); }

.styled-table {
  width: 100%; border-collapse: collapse; margin: 20px 0;
  background: var(--card); border-radius: var(--radius);
  overflow: hidden; box-shadow: var(--shadow);
}
.styled-table thead { background: var(--primary); color: #fff; }
.styled-table th { padding: 16px 20px; text-align: left; font-weight: 600; }
.styled-table td { padding: 14px 20px; border-bottom: 1px solid #eee; }
.styled-table tbody tr:hover { background: #f7fafc; }

.timeline { position: relative; padding-left: 40px; margin: 30px 0; }
.timeline::before {
  content: '';
  position: absolute; left: 12px; top: 0; bottom: 0;
  width: 3px;
  background: linear-gradient(to bottom, var(--primary-light), var(--accent));
  border-radius: 3px;
}
.timeline-item {
  position: relative; margin-bottom: 30px; padding: 24px;
  background: var(--card); border-radius: var(--radius); box-shadow: var(--shadow);
}
.timeline-item::before {
  content: ''; position: absolute;
  left: -34px; top: 30px;
  width: 16px; height: 16px;
  background: var(--accent); border-radius: 50%; border: 3px solid var(--bg);
}
.timeline-item h4 { color: var(--primary); font-size: 18px; margin-bottom: 8px; }
.timeline-item p { color: var(--text-light); }
.timeline-item .time-label {
  display: inline-block; background: var(--primary); color: #fff;
  padding: 4px 14px; border-radius: 20px; font-size: 13px; margin-bottom: 10px;
}

.stats-row {
  display: grid;
  grid-template-columns: repeat(auto-fill, minmax(200px, 1fr));
  gap: 20px; margin: 30px 0;
}
.stat-box {
  background: linear-gradient(135deg, var(--card) 0%, #f7fafc 100%);
  border-radius: var(--radius); padding: 24px; text-align: center;
  box-shadow: var(--shadow); border-bottom: 3px solid var(--primary-light);
  transition: var(--transition);
}
.stat-box:nth-child(2) { border-bottom-color: var(--accent); }
.stat-box:nth-child(3) { border-bottom-color: var(--warm); }
.stat-box:nth-child(4) { border-bottom-color: var(--warm-dark); }
.stat-box:hover { transform: translateY(-4px); box-shadow: var(--shadow-hover); }
.stat-box .stat-num {
  font-size: 36px; font-weight: 800;
  background: linear-gradient(135deg, var(--primary), var(--accent));
  -webkit-background-clip: text; -webkit-text-fill-color: transparent; background-clip: text;
}
.stat-box .stat-label { color: var(--text-light); font-size: 14px; margin-top: 6px; }

.carepedia-cta {
  background: linear-gradient(135deg, #1A73E8, #00C9A7);
  padding: 48px 24px; text-align: center; color: #fff;
}
.carepedia-cta h3 { font-size: 24px; font-weight: 700; margin-bottom: 12px; }
.carepedia-cta p { font-size: 16px; opacity: 0.9; margin-bottom: 24px; max-width: 500px; margin-left: auto; margin-right: auto; }
.carepedia-cta .cta-btn {
  display: inline-flex; align-items: center; gap: 8px;
  padding: 14px 32px; background: #fff; color: #1A73E8;
  text-decoration: none; border-radius: 30px; font-size: 16px; font-weight: 700;
  font-family: inherit; transition: all 0.3s ease; box-shadow: 0 4px 16px rgba(0,0,0,0.15);
}
.carepedia-cta .cta-btn:hover { transform: translateY(-2px); box-shadow: 0 8px 24px rgba(0,0,0,0.2); }

.credit-bar {
  display: flex; align-items: center; justify-content: center; gap: 16px; flex-wrap: wrap;
  padding: 14px 20px; font-size: 14px; color: rgba(255,255,255,0.85); position: relative; z-index: 1;
}
.credit-bar span { opacity: 0.9; }
.portal-request-btn {
  display: inline-flex; align-items: center; gap: 8px;
  padding: 10px 22px; background: var(--primary-light); color: #fff;
  text-decoration: none; border-radius: 30px; font-size: 14px;
  font-family: inherit; font-weight: 600; transition: var(--transition);
  box-shadow: 0 2px 12px rgba(0,0,0,0.15);
}
.portal-request-btn:hover { background: var(--primary); transform: translateY(-2px); box-shadow: 0 4px 20px rgba(0,0,0,0.2); }

.footer {
  background: var(--primary); color: rgba(255,255,255,0.8);
  text-align: center; padding: 40px; font-size: 14px;
}

.scroll-top {
  position: fixed; bottom: 30px; left: 30px;
  width: 50px; height: 50px; background: var(--primary);
  color: #fff; border: none; border-radius: 50%;
  font-size: 22px; cursor: pointer; box-shadow: var(--shadow);
  transition: var(--transition); opacity: 0; pointer-events: none; z-index: 999;
}
.scroll-top.visible { opacity: 1; pointer-events: auto; }
.scroll-top:hover { background: var(--primary-light); transform: translateY(-3px); }

.search-box { position: relative; margin: 0 auto; }
.search-box input {
  width: 100%; padding: 14px 20px 14px 50px;
  border: 2px solid rgba(15,76,117,0.15); border-radius: 30px;
  font-size: 16px; font-family: 'Rubik', sans-serif;
  background: var(--card); color: var(--text); transition: var(--transition);
  box-sizing: border-box;
}
.search-box input:focus { outline: none; border-color: var(--primary-light); box-shadow: 0 0 0 4px rgba(50,130,184,0.1); }
.search-box .search-icon {
  position: absolute; left: 18px; top: 50%;
  transform: translateY(-50%); font-size: 20px; pointer-events: none;
}

.sidebar-overlay {
  display: none; position: fixed; top: 0; left: 0; right: 0; bottom: 0;
  background: rgba(0,0,0,0.5); z-index: 999; opacity: 0; transition: opacity 0.3s ease;
}
.sidebar-overlay.active { display: block; opacity: 1; }

@media (max-width: 900px) {
  .sidebar { transform: translateX(-100%); width: 270px; }
  .sidebar.open { transform: translateX(0); }
  .menu-toggle { display: block; }
  .main { margin-left: 0; }
  .hero { padding: 60px 30px; }
  .section { padding: 40px 24px; }
}

@media (max-width: 768px) {
  .sidebar { transform: translateX(-100%); width: 260px; }
  .sidebar.open { transform: translateX(0); }
  .menu-toggle { display: block; }
  .main { margin-left: 0; }
  .hero { padding: 40px 20px 36px; }
  .hero h1 { font-size: 28px; line-height: 1.3; }
  .hero .greeting { font-size: 16px; line-height: 1.7; }
  .hero .subtitle { font-size: 14px; }
  .section { padding: 28px 16px; }
  .section-header { flex-direction: column; align-items: flex-start; gap: 8px; margin-bottom: 24px; padding-bottom: 14px; }
  .section-header .sec-icon { font-size: 32px; }
  .section-header h2 { font-size: 24px; }
  .section-header p { font-size: 14px; }
  .cards-grid { grid-template-columns: 1fr; gap: 16px; margin-bottom: 24px; }
  .card { padding: 20px; }
  .card:hover { transform: none; }
  .cat-card:hover { transform: none; }
  .stat-box:hover { transform: none; }
  .link-btn:hover { transform: none; }
  .portal-request-btn:hover { transform: none; }
  .scroll-top:hover { transform: none; }
  .sidebar nav a:hover { transform: none; }
  .card .card-icon { font-size: 32px; margin-bottom: 10px; }
  .card h3 { font-size: 17px; }
  .card p { font-size: 14px; }
  .cat-grid { grid-template-columns: repeat(2, 1fr); gap: 12px; margin-top: 24px; }
  .cat-card { padding: 18px 12px; }
  .cat-card .cat-icon { font-size: 32px; margin-bottom: 8px; }
  .cat-card h3 { font-size: 14px; }
  .cat-card p { font-size: 11px; }
  .stats-row { grid-template-columns: repeat(2, 1fr); gap: 12px; margin: 20px 0; }
  .stat-box { padding: 16px 10px; }
  .stat-box .stat-num { font-size: 26px; }
  .stat-box .stat-label { font-size: 12px; }
  .tabs { gap: 6px; margin-bottom: 16px; }
  .tab-btn { padding: 8px 14px; font-size: 13px; border-radius: 20px; }
  .styled-table { display: block; overflow-x: auto; -webkit-overflow-scrolling: touch; font-size: 13px; }
  .styled-table th { padding: 10px 12px; font-size: 13px; white-space: nowrap; }
  .styled-table td { padding: 10px 12px; font-size: 13px; min-width: 100px; }
  .info-box { padding: 16px 18px; margin: 16px 0; }
  .info-box h4 { font-size: 15px; }
  .info-box p { font-size: 13px; }
  .accordion-header { padding: 14px 16px; font-size: 15px; }
  .accordion-body .inner { padding: 14px 16px 18px; font-size: 14px; line-height: 1.9; }
  .timeline { padding-left: 30px; margin: 20px 0; }
  .timeline-item { padding: 16px; margin-bottom: 20px; }
  .timeline-item::before { left: -24px; width: 12px; height: 12px; top: 22px; }
  .timeline-item h4 { font-size: 16px; }
  .timeline-item p { font-size: 13px; }
  .link-btn { padding: 10px 16px; font-size: 13px; margin: 4px 2px; }
  .search-box input { padding: 12px 18px 12px 40px; font-size: 14px; }
  .footer { padding: 28px 16px; font-size: 13px; }
  .scroll-top { width: 42px; height: 42px; font-size: 18px; bottom: 20px; left: 16px; }
}

@media (max-width: 380px) {
  .hero h1 { font-size: 24px; }
  .hero .greeting { font-size: 15px; }
  .cat-grid { grid-template-columns: 1fr 1fr; gap: 8px; }
  .cat-card { padding: 14px 8px; }
  .cat-card .cat-icon { font-size: 26px; }
  .cat-card h3 { font-size: 13px; }
  .cat-card p { display: none; }
  .stats-row { grid-template-columns: 1fr 1fr; gap: 8px; }
  .stat-box .stat-num { font-size: 22px; }
  .section { padding: 20px 12px; }
  .tab-btn { padding: 7px 10px; font-size: 12px; }
}

.disclaimer-banner {
  background: linear-gradient(135deg, #FFF3E0, #FFF8E1);
  border-bottom: 2px solid #FFB74D;
  padding: 10px 20px; text-align: center; font-size: 13px; color: #5D4037;
  position: relative; z-index: 1500;
  display: flex; align-items: center; justify-content: center; gap: 8px; flex-wrap: wrap;
}
.disclaimer-banner strong { color: #E65100; }
.disclaimer-banner a { color: #1A73E8; text-decoration: underline; font-weight: 600; }
.disclaimer-banner a:hover { color: #0D47A1; }
@media (max-width: 768px) { .disclaimer-banner { font-size: 12px; padding: 8px 12px; } }
</style>
<script src="https://code.iconify.design/iconify-icon/2.1.0/iconify-icon.min.js" defer></script>
</head>
<body>

<div class="scroll-progress"><div class="bar" id="scrollBar"></div></div>
<div class="sidebar-overlay" id="overlay" onclick="closeMenu()"></div>

<button class="menu-toggle" id="menuToggle" onclick="toggleMenu()">
  <iconify-icon icon="mdi:menu"></iconify-icon>
</button>

<aside class="sidebar" id="sidebar">
  <div class="logo">
    <div class="icon"><iconify-icon icon="mdi:wheelchair" style="color:#fff;font-size:48px;"></iconify-icon></div>
    <h2>Cerebral Palsy Hub</h2>
  </div>
  <nav>
    <a href="#home" class="active" onclick="navigateTo('home')"><span class="nav-icon"><iconify-icon icon="mdi:home"></iconify-icon></span> Home</a>
    <a href="#about" onclick="navigateTo('about')"><span class="nav-icon"><iconify-icon icon="mdi:information"></iconify-icon></span> About CP</a>
    <a href="#treatments" onclick="navigateTo('treatments')"><span class="nav-icon"><iconify-icon icon="mdi:pill"></iconify-icon></span> Treatments</a>
    <a href="#trials" onclick="navigateTo('trials')"><span class="nav-icon"><iconify-icon icon="mdi:flask"></iconify-icon></span> Clinical Trials</a>
    <a href="#research" onclick="navigateTo('research')"><span class="nav-icon"><iconify-icon icon="mdi:microscope"></iconify-icon></span> Research</a>
    <a href="#children" onclick="navigateTo('children')"><span class="nav-icon"><iconify-icon icon="mdi:baby-face"></iconify-icon></span> Young Children</a>
    <a href="#lifestyle" onclick="navigateTo('lifestyle')"><span class="nav-icon"><iconify-icon icon="mdi:run"></iconify-icon></span> Lifestyle &amp; Sport</a>
    <a href="#nutrition" onclick="navigateTo('nutrition')"><span class="nav-icon"><iconify-icon icon="mdi:food-apple"></iconify-icon></span> Nutrition</a>
    <a href="#psychological-approach" onclick="navigateTo('psychological-approach')"><span class="nav-icon"><iconify-icon icon="mdi:head-heart"></iconify-icon></span> Psychological Support</a>
    <a href="#international" onclick="navigateTo('international')"><span class="nav-icon"><iconify-icon icon="mdi:earth"></iconify-icon></span> Global Resources</a>
    <a href="#emergency" onclick="navigateTo('emergency')"><span class="nav-icon"><iconify-icon icon="mdi:alarm-light"></iconify-icon></span> Emergency</a>
    <a href="#stories" onclick="navigateTo('stories')"><span class="nav-icon"><iconify-icon icon="mdi:account-voice"></iconify-icon></span> Stories</a>
    <a href="#resources" onclick="navigateTo('resources')"><span class="nav-icon"><iconify-icon icon="mdi:link"></iconify-icon></span> Resources</a>
  </nav>
</aside>

<main class="main">

  <div class="disclaimer-banner">
    <iconify-icon icon="mdi:alert-circle-outline" style="font-size:18px;color:#E65100;"></iconify-icon>
    <strong>Medical Disclaimer:</strong> This portal is for informational purposes only and does not replace professional medical advice.
    Always consult a qualified physician before making any medical decision.
  </div>

  <!-- HOME -->
  <section id="home" class="hero">
    <div class="hero-content">
      <h1><iconify-icon icon="mdi:wheelchair" style="vertical-align:middle;margin-right:12px;"></iconify-icon>Cerebral Palsy</h1>
      <p class="greeting">A comprehensive, evidence-based information hub for people with CP, their families, and healthcare professionals — treatments, research, adaptive sports, and global support resources.</p>
      <p class="subtitle">Cerebral palsy is the most common physical disability in childhood, affecting approximately 17 million people worldwide. CP is not a single condition but a group of permanent neurological disorders affecting movement, posture, and muscle tone.</p>
    </div>
  </section>

  <div class="section fade-in">
    <div class="stats-row">
      <div class="stat-box"><div class="stat-num">17M+</div><div class="stat-label">People with CP worldwide</div></div>
      <div class="stat-box"><div class="stat-num">0.8:1,000</div><div class="stat-label">Global prevalence (live births)</div></div>
      <div class="stat-box"><div class="stat-num">80%</div><div class="stat-label">Spastic type (most common)</div></div>
      <div class="stat-box"><div class="stat-num">30%</div><div class="stat-label">Identified genetic component</div></div>
    </div>
    <div class="cards-grid">
      <div class="card">
        <div class="card-icon"><iconify-icon icon="mdi:brain"></iconify-icon></div>
        <h3>What Is Cerebral Palsy?</h3>
        <p>CP refers to a group of permanent but non-progressive neurological disorders affecting movement, muscle tone, and posture, caused by injury or abnormal development of the brain before, during, or shortly after birth. "Cerebral" refers to the brain; "palsy" to motor impairment.</p>
      </div>
      <div class="card green">
        <div class="card-icon"><iconify-icon icon="mdi:pill"></iconify-icon></div>
        <h3>Treatments Available</h3>
        <p>Botulinum toxin (Dysport FDA-approved for pediatric spasticity), baclofen (oral and intrathecal), SDR surgery, physiotherapy, CIMT, HABIT, and goal-directed training. Research advances include cord blood therapy and DBS.</p>
      </div>
      <div class="card orange">
        <div class="card-icon"><iconify-icon icon="mdi:run"></iconify-icon></div>
        <h3>Active Living</h3>
        <p>Swimming, boccia, hippotherapy, frame running, adaptive cycling, yoga, and wheelchair dancing. People with CP participate in sports from local clubs to the Paralympic Games.</p>
      </div>
    </div>
    <div class="cat-grid">
      <a class="cat-card" onclick="navigateTo('about')"><div class="cat-icon"><iconify-icon icon="mdi:information-outline"></iconify-icon></div><h3>About CP</h3><p>Types, causes &amp; GMFCS</p></a>
      <a class="cat-card" onclick="navigateTo('treatments')"><div class="cat-icon"><iconify-icon icon="mdi:pill"></iconify-icon></div><h3>Treatments</h3><p>Medications &amp; therapies</p></a>
      <a class="cat-card" onclick="navigateTo('trials')"><div class="cat-icon"><iconify-icon icon="mdi:flask"></iconify-icon></div><h3>Clinical Trials</h3><p>Active research studies</p></a>
      <a class="cat-card" onclick="navigateTo('research')"><div class="cat-icon"><iconify-icon icon="mdi:microscope"></iconify-icon></div><h3>Research</h3><p>Latest discoveries</p></a>
      <a class="cat-card" onclick="navigateTo('lifestyle')"><div class="cat-icon"><iconify-icon icon="mdi:run"></iconify-icon></div><h3>Lifestyle</h3><p>Sport &amp; adaptive activities</p></a>
      <a class="cat-card" onclick="navigateTo('international')"><div class="cat-icon"><iconify-icon icon="mdi:earth"></iconify-icon></div><h3>Global Resources</h3><p>International organizations</p></a>
      <a class="cat-card" onclick="navigateTo('stories')"><div class="cat-icon"><iconify-icon icon="mdi:account-voice"></iconify-icon></div><h3>Stories</h3><p>Lives lived fully</p></a>
      <a class="cat-card" onclick="navigateTo('resources')"><div class="cat-icon"><iconify-icon icon="mdi:link"></iconify-icon></div><h3>Resources</h3><p>Organizations &amp; links</p></a>
    </div>
  </div>

  <!-- ABOUT -->
  <section id="about" class="section fade-in">
    <div class="section-header">
      <div class="sec-icon"><iconify-icon icon="mdi:information"></iconify-icon></div>
      <div><h2>About Cerebral Palsy</h2><p>Types, causes, classification, and diagnosis</p></div>
    </div>
    <div class="cards-grid">
      <div class="card">
        <div class="card-icon"><iconify-icon icon="mdi:brain"></iconify-icon></div>
        <h3>Types of CP</h3>
        <p><strong>Spastic CP (80%)</strong> — increased muscle tone, stiff movements. Subtypes: spastic diplegia (legs primarily), spastic hemiplegia (one side), spastic quadriplegia (all limbs). <strong>Dyskinetic/Athetoid CP</strong> — involuntary, writhing movements. <strong>Ataxic CP</strong> — affects balance and coordination. <strong>Mixed</strong> — combination of features.</p>
      </div>
      <div class="card green">
        <div class="card-icon"><iconify-icon icon="mdi:alert"></iconify-icon></div>
        <h3>Causes</h3>
        <p>Prenatal (brain malformations, infections, genetic factors — ~30%), perinatal (birth asphyxia, premature birth, low birth weight), and postnatal (head injury, stroke, meningitis — up to age 2). In ~25% of cases, no clear cause is identified even after full investigation.</p>
      </div>
      <div class="card orange">
        <div class="card-icon"><iconify-icon icon="mdi:chart-bar"></iconify-icon></div>
        <h3>GMFCS Classification</h3>
        <p>The Gross Motor Function Classification System (GMFCS) levels I–V describes motor function: Level I (walks without limitations), Level II (walks with limitations), Level III (walks with hand-held mobility aids), Level IV (self-mobility with limitations, may use powered chair), Level V (transported in manual wheelchair).</p>
      </div>
    </div>
    <div class="accordion">
      <div class="accordion-header" onclick="toggleAccordion(this)">How is CP diagnosed? <span class="arrow">&#9660;</span></div>
      <div class="accordion-body"><div class="inner">
        <p>CP is a clinical diagnosis based on neurological examination, developmental history, and brain imaging (MRI). The General Movement Assessment (GMA) can identify motor abnormalities as early as 2–4 months of age — enabling very early diagnosis. MRI findings are abnormal in ~80% of CP cases. Genetic testing is recommended to identify monogenic causes, particularly when MRI is normal.</p>
      </div></div>
    </div>
    <div class="accordion">
      <div class="accordion-header" onclick="toggleAccordion(this)">Associated conditions <span class="arrow">&#9660;</span></div>
      <div class="accordion-body"><div class="inner">
        <p>CP frequently co-occurs with: epilepsy (25–45%), intellectual disability (up to 50%), vision impairment (40%), hearing impairment (15%), speech and communication difficulties (50–80%), pain (75%), and sleep disturbances (40%). Each of these requires separate assessment and management. Pain is the most underrecognized and undertreated comorbidity in CP.</p>
      </div></div>
    </div>
    <div class="accordion">
      <div class="accordion-header" onclick="toggleAccordion(this)">CP is not progressive — but needs are lifelong <span class="arrow">&#9660;</span></div>
      <div class="accordion-body"><div class="inner">
        <p>The brain injury causing CP does not worsen, but the functional impact changes across the lifespan. Children may gain skills with intervention; adults may experience functional decline due to musculoskeletal changes, pain, and fatigue. Transition from pediatric to adult care is a critical and often challenging period. Adult CP care is underresourced worldwide and is an active area of advocacy and research.</p>
      </div></div>
    </div>
  </section>

  <!-- TREATMENTS -->
  <section id="treatments" class="section fade-in">
    <div class="section-header">
      <div class="sec-icon"><iconify-icon icon="mdi:pill"></iconify-icon></div>
      <div><h2>Treatments</h2><p>Medications, therapies, and surgical options</p></div>
    </div>
    <div class="tabs">
      <button class="tab-btn active" onclick="switchTab(this,'medications')">Medications</button>
      <button class="tab-btn" onclick="switchTab(this,'therapies')">Therapies</button>
      <button class="tab-btn" onclick="switchTab(this,'surgery')">Surgery</button>
      <button class="tab-btn" onclick="switchTab(this,'cp-questions')">Key Questions</button>
    </div>

    <div id="medications" class="tab-content active">
      <table class="styled-table">
        <thead><tr><th>Medication</th><th>Target</th><th>Notes</th></tr></thead>
        <tbody>
          <tr><td><strong>Botulinum Toxin A (Dysport, Botox)</strong></td><td>Focal spasticity</td><td>Dysport FDA-approved 2023 for pediatric lower limb spasticity. Injected into target muscles; effect lasts 3–6 months. Usually combined with intensive physiotherapy for maximum benefit.</td></tr>
          <tr><td><strong>Oral Baclofen</strong></td><td>Generalized spasticity</td><td>GABA-B agonist. Effective for widespread spasticity. Side effects include sedation and weakness. Commonly used from school age onwards.</td></tr>
          <tr><td><strong>Intrathecal Baclofen (ITB)</strong></td><td>Severe spasticity / dystonia</td><td>Delivered directly to spinal fluid via implanted pump. Far higher efficacy at lower doses. Requires surgical implantation and regular pump refills.</td></tr>
          <tr><td><strong>Diazepam</strong></td><td>Spasticity / muscle spasm</td><td>Benzodiazepine. Short-term use for acute muscle spasm or during orthopedic recovery. Long-term use limited by sedation and dependence risk.</td></tr>
          <tr><td><strong>Trihexyphenidyl</strong></td><td>Dystonia</td><td>Anticholinergic used for dyskinetic CP. Requires careful titration; side effects include dry mouth and constipation.</td></tr>
          <tr><td><strong>Levodopa / Carbidopa</strong></td><td>Dopa-responsive dystonia</td><td>Highly effective in dopa-responsive dystonia (DRD) — a condition sometimes misdiagnosed as CP. Trial of levodopa is recommended in most children with dystonic CP.</td></tr>
        </tbody>
      </table>
    </div>

    <div id="therapies" class="tab-content">
      <div class="cards-grid">
        <div class="card">
          <div class="card-icon"><iconify-icon icon="mdi:walk"></iconify-icon></div>
          <h3>Physiotherapy</h3>
          <p>Core of CP rehabilitation. Approaches include Goal-Directed Training (GDT), Gross Motor Function Measure (GMFM)-guided therapy, and task-specific practice. High-intensity, goal-directed physiotherapy shows strong evidence. Aquatic therapy provides low-impact movement in warm water.</p>
        </div>
        <div class="card green">
          <div class="card-icon"><iconify-icon icon="mdi:hand-back-right"></iconify-icon></div>
          <h3>Constraint-Induced Movement Therapy (CIMT)</h3>
          <p>For hemiplegic CP — constrains the less-affected hand while intensively practicing the affected hand. HABIT (Hand-Arm Bimanual Intensive Therapy) trains both hands simultaneously. Both are among the most evidence-based interventions for upper limb function in CP.</p>
        </div>
        <div class="card orange">
          <div class="card-icon"><iconify-icon icon="mdi:microphone"></iconify-icon></div>
          <h3>Speech-Language Therapy</h3>
          <p>Up to 80% of children with CP have speech or communication difficulties. SLP addresses articulation, augmentative and alternative communication (AAC), feeding, and swallowing. Early AAC introduction supports language development even before expressive speech emerges.</p>
        </div>
      </div>
      <div class="cards-grid">
        <div class="card">
          <div class="card-icon"><iconify-icon icon="mdi:horse"></iconify-icon></div>
          <h3>Hippotherapy</h3>
          <p>Therapeutic horseback riding uses the horse's three-dimensional movement to improve trunk control, balance, and posture. Studies show improvements in gross motor function and quality of life. Widely available through certified hippotherapy centers globally.</p>
        </div>
        <div class="card green">
          <div class="card-icon"><iconify-icon icon="mdi:robot"></iconify-icon></div>
          <h3>Robotic Rehabilitation</h3>
          <p>Exoskeleton-based gait training (Lokomat, EksoNR, Hocoma), robotic arm therapy (ArmeoSpring), and robotic orthotics provide high-repetition, task-specific practice. Evidence is growing for improved gait and upper limb function in children and adults with CP.</p>
        </div>
        <div class="card orange">
          <div class="card-icon"><iconify-icon icon="mdi:swim"></iconify-icon></div>
          <h3>Aquatic Therapy</h3>
          <p>Warm-water therapy reduces spasticity, supports movement, and improves cardiovascular fitness. Many children who cannot walk on land can walk in water — a powerful motivational and therapeutic tool. Swimming also supports social inclusion and sport participation.</p>
        </div>
      </div>
    </div>

    <div id="surgery" class="tab-content">
      <div class="cards-grid">
        <div class="card">
          <div class="card-icon"><iconify-icon icon="mdi:medical-bag"></iconify-icon></div>
          <h3>Selective Dorsal Rhizotomy (SDR)</h3>
          <p>Surgical procedure that selectively cuts sensory nerve rootlets at the spinal level to permanently reduce spasticity in lower limbs. Best evidence for ambulatory children with spastic diplegia (GMFCS I–III). Requires intensive post-operative physiotherapy for 12–24 months. Long-term outcomes are positive in carefully selected patients.</p>
        </div>
        <div class="card green">
          <div class="card-icon"><iconify-icon icon="mdi:bone"></iconify-icon></div>
          <h3>Orthopedic Surgery</h3>
          <p>Single-event multilevel surgery (SEMLS) corrects multiple musculoskeletal problems at once (tendon lengthening, osteotomy, muscle transfers), reducing the number of surgical procedures over a lifetime. Gait analysis (3D instrumented gait analysis) guides surgical planning. Hip surveillance programs reduce hip dislocation rates in high-risk children.</p>
        </div>
        <div class="card orange">
          <div class="card-icon"><iconify-icon icon="mdi:lightning-bolt"></iconify-icon></div>
          <h3>Deep Brain Stimulation (DBS)</h3>
          <p>For severe dystonic CP, DBS delivers continuous electrical stimulation to the globus pallidus interna (GPi), reducing involuntary movements. UCSF has published promising results in pediatric cerebellar DBS for CP. DBS is reserved for cases where medications and other interventions are insufficient.</p>
        </div>
      </div>
    </div>

    <div id="cp-questions" class="tab-content">
      <div class="info-box success">
        <h4>Important Questions for Your CP Specialist</h4>
        <p>Bring these questions to your next appointment:</p>
      </div>
      <div class="accordion">
        <div class="accordion-header" onclick="toggleAccordion(this)">Questions about botulinum toxin <span class="arrow">&#9660;</span></div>
        <div class="accordion-body"><div class="inner">
          <p>Which muscles are candidates for botulinum toxin injection? How often would we repeat the injections? What intensive physiotherapy should we combine with the injections? Are there goals we should set to measure whether treatment is working? What are the realistic benefits for our child's specific GMFCS level?</p>
        </div></div>
      </div>
      <div class="accordion">
        <div class="accordion-header" onclick="toggleAccordion(this)">Questions about SDR surgery <span class="arrow">&#9660;</span></div>
        <div class="accordion-body"><div class="inner">
          <p>Does my child meet the candidacy criteria for SDR? What does 3D gait analysis show, and does it support surgical intervention? How do I find an experienced SDR surgical center? What is the realistic expectation for walking improvement? What does the 12–24 month post-operative physiotherapy program involve?</p>
        </div></div>
      </div>
      <div class="accordion">
        <div class="accordion-header" onclick="toggleAccordion(this)">Questions about pain management <span class="arrow">&#9660;</span></div>
        <div class="accordion-body"><div class="inner">
          <p>How do we assess pain in my child (especially if communication is limited)? What is the likely source of pain (muscle, joint, GI, neuropathic)? What is the role of spasticity treatment in pain reduction? Are there physiotherapy approaches specifically for pain management? Should we consult a pain specialist?</p>
        </div></div>
      </div>
    </div>
  </section>

  <!-- CLINICAL TRIALS -->
  <section id="trials" class="section fade-in">
    <div class="section-header">
      <div class="sec-icon"><iconify-icon icon="mdi:flask"></iconify-icon></div>
      <div><h2>Clinical Trials</h2><p>Active research studies and how to participate</p></div>
    </div>
    <div class="timeline">
      <div class="timeline-item">
        <div class="time-label">Duke University</div>
        <h4>Cord Blood Therapy (NCT03327467)</h4>
        <p>Duke University's Phase 2 trial uses autologous (the child's own) umbilical cord blood infusions to attempt neuroprotection and repair. Early Phase 1 results showed safety and modest functional improvements. The Phase 2 placebo-controlled trial is ongoing with participants across multiple US sites.</p>
      </div>
      <div class="timeline-item">
        <div class="time-label">UCSF</div>
        <h4>Cerebellar Deep Brain Stimulation</h4>
        <p>University of California, San Francisco is running trials of DBS targeting the cerebellum (rather than the globus pallidus) in children and adults with CP. Early results show improvements in spasticity, coordination, and gait. This is a novel target not previously used in CP.</p>
      </div>
      <div class="timeline-item">
        <div class="time-label">NeuralNET (UK)</div>
        <h4>Genome Sequencing in CP</h4>
        <p>The UK's 100,000 Genomes Project and NeuralNET consortium are conducting whole-genome sequencing in CP to identify genetic causes, biomarkers, and potential therapeutic targets. Genetic diagnosis changes management in ~25% of cases where a pathogenic variant is found.</p>
      </div>
      <div class="timeline-item">
        <div class="time-label">Multiple Sites</div>
        <h4>Spinal Cord Stimulation for CP</h4>
        <p>Building on successful use in spinal cord injury, transcutaneous spinal cord stimulation (tSCS) is being trialed in CP to improve lower limb function and gait. Phase 2 trials are ongoing in the US, Australia, and Europe.</p>
      </div>
      <div class="timeline-item">
        <div class="time-label">Cryo-Cell International</div>
        <h4>Cord Blood Phase 3</h4>
        <p>Phase 3 trial of umbilical cord blood infusion for CP across multiple centers. Uses both autologous and donor cord blood. Enrollment open for children aged 1–5 with CP diagnosis and available cord blood unit.</p>
      </div>
      <div class="timeline-item">
        <div class="time-label">NTI164 (Australia)</div>
        <h4>Medicinal Cannabis — Spasticity</h4>
        <p>Australian Phase 2 trials of NTI164, a high-cannabidiol medicinal cannabis product, for spasticity and motor function in CP. Early results show positive effects on spasticity scores and sleep. Phase 3 planning underway.</p>
      </div>
    </div>
    <div style="margin-top:20px;">
      <a href="https://clinicaltrials.gov/search?cond=cerebral+palsy" target="_blank" class="link-btn"><iconify-icon icon="mdi:flask"></iconify-icon> ClinicalTrials.gov</a>
      <a href="https://www.cparf.org/research/clinical-trials/" target="_blank" class="link-btn green"><iconify-icon icon="mdi:magnify"></iconify-icon> CPARF Trial Finder</a>
      <a href="https://canchild.ca/" target="_blank" class="link-btn orange"><iconify-icon icon="mdi:earth"></iconify-icon> CanChild Research</a>
    </div>
  </section>

  <!-- RESEARCH -->
  <section id="research" class="section fade-in">
    <div class="section-header">
      <div class="sec-icon"><iconify-icon icon="mdi:microscope"></iconify-icon></div>
      <div><h2>Research Highlights</h2><p>Latest scientific developments in CP</p></div>
    </div>
    <div class="timeline">
      <div class="timeline-item">
        <div class="time-label">2025</div>
        <h4>Stem Cell Meta-Analysis</h4>
        <p>A comprehensive 2025 systematic review and meta-analysis of stem cell trials in CP (published in Developmental Medicine &amp; Child Neurology) confirmed statistically significant improvements in gross motor function and cognitive outcomes with cord blood therapy in children under 5. This represents the strongest evidence base yet for cell-based approaches.</p>
      </div>
      <div class="timeline-item">
        <div class="time-label">2024</div>
        <h4>Genetic Discoveries — KANK1, AP-4 Complex</h4>
        <p>Whole-genome and exome sequencing studies published in 2024 identified multiple new genes associated with CP-like presentations, including KANK1 variants (spastic diplegia-like) and AP-4 complex genes (hereditary spastic paraplegia mimicking CP). Genetic diagnosis has implications for prognosis, recurrence counseling, and eventually targeted treatment.</p>
      </div>
      <div class="timeline-item">
        <div class="time-label">2024</div>
        <h4>Dysport FDA Approval — Pediatric Spasticity</h4>
        <p>In 2024, the FDA approved Dysport (abobotulinumtoxinA) for lower limb spasticity in pediatric patients with CP — a significant regulatory milestone. Prior use was off-label in children. The approval was based on multicenter randomized controlled trial data demonstrating safety and efficacy.</p>
      </div>
      <div class="timeline-item">
        <div class="time-label">2023–2024</div>
        <h4>Brain-Computer Interfaces (BCI) in CP</h4>
        <p>BCI systems that translate neural signals directly into movement commands or device control are advancing rapidly. Studies in adults with CP show that BCI can enable individuals with severe motor impairment to control computers, communication devices, and robotic arms using neural signals alone. Pediatric BCI trials are in planning stages.</p>
      </div>
      <div class="timeline-item">
        <div class="time-label">2023</div>
        <h4>SDR Long-Term Outcomes Study</h4>
        <p>A 20-year follow-up study of selective dorsal rhizotomy (SDR) outcomes, published in JAMA Neurology, confirmed durable reduction in spasticity and maintained walking ability into early adulthood in appropriately selected candidates. This study significantly strengthened the evidence base for SDR as a long-term intervention.</p>
      </div>
    </div>
  </section>

  <!-- CHILDREN -->
  <section id="children" class="section fade-in">
    <div class="section-header">
      <div class="sec-icon"><iconify-icon icon="mdi:baby-face"></iconify-icon></div>
      <div><h2>Young Children with CP</h2><p>Early intervention and development</p></div>
    </div>
    <div class="info-box success">
      <h4>The Critical Window: Early Intervention</h4>
      <p>The first three years of life represent a critical window of brain plasticity. Early, intensive, and goal-directed intervention during this period produces the greatest functional gains. The goal is to maximize every child's individual potential — not to achieve a normative developmental milestone.</p>
    </div>
    <div class="cards-grid">
      <div class="card">
        <div class="card-icon"><iconify-icon icon="mdi:baby"></iconify-icon></div>
        <h3>GAME (Goals, Activity, Motor Enrichment)</h3>
        <p>An evidence-based home program for infants at high risk for CP, involving parent-delivered motor enrichment activities targeting each child's specific goals. Randomized controlled trial evidence shows significant gains in motor function and cognitive development vs. standard physiotherapy alone.</p>
      </div>
      <div class="card green">
        <div class="card-icon"><iconify-icon icon="mdi:human-male-child"></iconify-icon></div>
        <h3>COPCA (COPing with and CAring for infants with special needs)</h3>
        <p>A family-centered early intervention approach that trains parents as the primary agents of their infant's therapeutic activities. Parents learn to incorporate therapeutic goals into everyday routines, dramatically increasing the "dose" of intervention the child receives.</p>
      </div>
      <div class="card orange">
        <div class="card-icon"><iconify-icon icon="mdi:hand-back-right"></iconify-icon></div>
        <h3>Baby-CIMT</h3>
        <p>Constraint-induced movement therapy adapted for infants as young as 3–6 months. The less-affected arm is briefly constrained while the infant is guided to use the affected arm in play. Evidence shows improvements in hand function that are maintained at long-term follow-up.</p>
      </div>
    </div>
    <div class="cards-grid">
      <div class="card">
        <div class="card-icon"><iconify-icon icon="mdi:tablet"></iconify-icon></div>
        <h3>Early AAC</h3>
        <p>Communication support should begin as early as the first months of life for children at risk. Augmentative and alternative communication (AAC) — from simple eye-gaze boards to high-tech devices — supports language development even before expressive speech. Proloquo2Go, TD Snap, and TouchChat are widely used apps.</p>
      </div>
      <div class="card green">
        <div class="card-icon"><iconify-icon icon="mdi:run-fast"></iconify-icon></div>
        <h3>Supported Standing &amp; Early Mobility</h3>
        <p>Upright positioning (standing frames) from early childhood promotes hip joint development, bone density, bowel function, and social participation. Powered mobility (ride-on toys adapted for children with CP) enables independent exploration and cognitive development from 18–24 months.</p>
      </div>
      <div class="card orange">
        <div class="card-icon"><iconify-icon icon="mdi:school"></iconify-icon></div>
        <h3>School Readiness</h3>
        <p>Educational accommodations (IEP in the US, EHC Plans in the UK) should be in place before school entry. Physical access, assistive technology, classroom aide support, and adapted physical education are all components. Neuropsychological evaluation helps identify learning profiles and optimize educational planning.</p>
      </div>
    </div>
  </section>

  <!-- LIFESTYLE -->
  <section id="lifestyle" class="section fade-in">
    <div class="section-header">
      <div class="sec-icon"><iconify-icon icon="mdi:run"></iconify-icon></div>
      <div><h2>Lifestyle &amp; Adaptive Sport</h2><p>Active living with cerebral palsy</p></div>
    </div>
    <div class="info-box success">
      <h4>Physical Activity Is Medicine in CP</h4>
      <p>Regular physical activity improves cardiovascular health, muscle strength, bone density, mood, and quality of life in people with CP — at every GMFCS level. The goal is participation in activities that are enjoyable, social, and achievable. "Sport" means whatever works for the individual.</p>
    </div>
    <div class="cards-grid">
      <div class="card">
        <div class="card-icon"><iconify-icon icon="mdi:swim"></iconify-icon></div>
        <h3>Swimming</h3>
        <p>Swimming is one of the most accessible and beneficial activities for people with CP. Warm water reduces spasticity and muscle tension; buoyancy supports movement. Paralympic swimming has CP-specific classifications. Many community pools offer adapted swimming programs.</p>
      </div>
      <div class="card green">
        <div class="card-icon"><iconify-icon icon="mdi:bowling"></iconify-icon></div>
        <h3>Boccia</h3>
        <p>Boccia is a Paralympic precision ball sport specifically designed for athletes with severe physical impairments. Athletes with CP in GMFCS levels IV–V (using wheelchairs) can compete at the highest level. Boccia is one of only two Paralympic sports designed exclusively for athletes with severe physical disabilities.</p>
      </div>
      <div class="card orange">
        <div class="card-icon"><iconify-icon icon="mdi:horse"></iconify-icon></div>
        <h3>Hippotherapy &amp; Para-Equestrian</h3>
        <p>Beyond therapeutic hippotherapy, para-equestrian is a Paralympic sport. Riders compete in dressage across four grades based on impairment. Equestrian activities improve trunk stability, proprioception, confidence, and social participation at all ability levels.</p>
      </div>
    </div>
    <div class="cards-grid">
      <div class="card">
        <div class="card-icon"><iconify-icon icon="mdi:run"></iconify-icon></div>
        <h3>Frame Running</h3>
        <p>Frame running (RaceRunning) is a sport for people who cannot run unaided. Participants use a three-wheeled frame for trunk support and propel themselves with their feet. It is an IPC-recognized Paralympic sport with growing international competition. Participation builds cardiovascular fitness, leg strength, and confidence.</p>
      </div>
      <div class="card green">
        <div class="card-icon"><iconify-icon icon="mdi:bike"></iconify-icon></div>
        <h3>Adaptive Cycling</h3>
        <p>Tricycles, hand cycles, recumbent bikes, and tandem cycling enable people at all GMFCS levels to experience cycling. Adaptive cycling has strong evidence for improving gross motor function, cardiovascular fitness, and participation. Many organizations provide adaptive bike lending programs.</p>
      </div>
      <div class="card orange">
        <div class="card-icon"><iconify-icon icon="mdi:yoga"></iconify-icon></div>
        <h3>Yoga &amp; Mindfulness</h3>
        <p>Adapted yoga programs improve flexibility, body awareness, and stress management in people with CP. Research shows reduced spasticity and improved sleep quality. Online yoga programs adapted for wheelchair users and those with limited mobility are widely available.</p>
      </div>
    </div>
  </section>

  <!-- NUTRITION -->
  <section id="nutrition" class="section fade-in">
    <div class="section-header">
      <div class="sec-icon"><iconify-icon icon="mdi:food-apple"></iconify-icon></div>
      <div><h2>Nutrition</h2><p>Feeding challenges and nutritional management in CP</p></div>
    </div>
    <div class="stats-row">
      <div class="stat-box"><div class="stat-num">93%</div><div class="stat-label">of children with CP have eating difficulties</div></div>
      <div class="stat-box"><div class="stat-num">60%</div><div class="stat-label">have dysphagia (swallowing difficulties)</div></div>
      <div class="stat-box"><div class="stat-num">50–75%</div><div class="stat-label">experience chronic constipation</div></div>
      <div class="stat-box"><div class="stat-num">30–40%</div><div class="stat-label">require nutritional supplements or tube feeding</div></div>
    </div>
    <div class="cards-grid">
      <div class="card">
        <div class="card-icon"><iconify-icon icon="mdi:food"></iconify-icon></div>
        <h3>Feeding Assessment</h3>
        <p>Videofluoroscopic swallow study (VFSS) and clinical swallowing evaluation by an SLP should be performed in all children with CP who show signs of feeding difficulty. Assessment guides texture modification decisions using the IDDSI (International Dysphagia Diet Standardisation Initiative) framework.</p>
      </div>
      <div class="card green">
        <div class="card-icon"><iconify-icon icon="mdi:stomach"></iconify-icon></div>
        <h3>Gastrostomy (G-tube)</h3>
        <p>When oral feeding cannot meet nutritional needs safely, gastrostomy tube feeding (PEG) is recommended. G-tube feeding improves nutritional status, reduces aspiration risk, reduces mealtime stress for families, and supports growth. Oral feeding for enjoyment can often continue alongside tube feeding.</p>
      </div>
      <div class="card orange">
        <div class="card-icon"><iconify-icon icon="mdi:scale-balance"></iconify-icon></div>
        <h3>Nutritional Goals</h3>
        <p>Achieving adequate energy intake for growth while managing weight (obesity risk in non-ambulatory CP, undernutrition risk in others). Calcium and vitamin D for bone health. Iron for prevention of anemia. Regular dietitian monitoring is essential. The ESPGHAN/ESPEN guidelines for CP nutrition provide evidence-based recommendations.</p>
      </div>
    </div>
    <div class="accordion">
      <div class="accordion-header" onclick="toggleAccordion(this)">Managing constipation in CP <span class="arrow">&#9660;</span></div>
      <div class="accordion-body"><div class="inner">
        <p>Constipation is nearly universal in non-ambulatory CP and highly prevalent across all levels. Management: adequate hydration, high-fiber diet (or fiber supplements), regular toileting routine, upright positioning, abdominal massage, polyethylene glycol (PEG/MiraLAX) as first-line medication, lactulose, and bisacodyl for breakthrough episodes. Severe constipation warrants specialist gastroenterology consultation.</p>
      </div></div>
    </div>
    <div class="accordion">
      <div class="accordion-header" onclick="toggleAccordion(this)">GERD and reflux in CP <span class="arrow">&#9660;</span></div>
      <div class="accordion-body"><div class="inner">
        <p>Gastroesophageal reflux disease (GERD) is extremely common in CP, particularly in those with severe motor impairment (GMFCS IV–V). It causes pain, feeding aversion, aspiration risk, and sleep disruption. Management includes positioning (upright 30–45 minutes after feeds), dietary modification, proton pump inhibitors (omeprazole, lansoprazole), and H2 blockers. Surgical anti-reflux procedures (Nissen fundoplication) may be indicated in severe cases.</p>
      </div></div>
    </div>
  </section>

  <!-- PSYCHOLOGICAL SUPPORT -->
  <section id="psychological-approach" class="section fade-in">
    <div class="section-header">
      <div class="sec-icon"><iconify-icon icon="mdi:head-heart"></iconify-icon></div>
      <div><h2>Psychological Support</h2><p>Mental health, coping, and family wellbeing</p></div>
    </div>
    <div class="cards-grid">
      <div class="card">
        <div class="card-icon"><iconify-icon icon="mdi:brain"></iconify-icon></div>
        <h3>Cognitive Behavioral Therapy (CBT)</h3>
        <p>CBT is effective for anxiety and depression in people with CP. It helps reframe negative thoughts about disability, build coping strategies, and improve quality of life. Adapted protocols are available for individuals with communication or cognitive differences. Online and telehealth CBT is increasingly available.</p>
      </div>
      <div class="card green">
        <div class="card-icon"><iconify-icon icon="mdi:leaf"></iconify-icon></div>
        <h3>Acceptance and Commitment Therapy (ACT)</h3>
        <p>ACT focuses on developing psychological flexibility — accepting difficult emotions related to disability rather than fighting them, while committing to actions that align with personal values. Particularly effective for chronic pain management in CP. ACT also supports parents in managing the emotional demands of CP caregiving.</p>
      </div>
      <div class="card orange">
        <div class="card-icon"><iconify-icon icon="mdi:meditation"></iconify-icon></div>
        <h3>Mindfulness-Based Stress Reduction (MBSR)</h3>
        <p>MBSR programs for people with CP and their caregivers reduce stress, improve emotional regulation, and reduce pain perception. Adapted mindfulness practices can be modified for individuals with physical and communication limitations. Studies show significant reductions in anxiety and caregiver burnout.</p>
      </div>
    </div>
    <div class="cards-grid">
      <div class="card">
        <div class="card-icon"><iconify-icon icon="mdi:human-male-female"></iconify-icon></div>
        <h3>Family-Centered Support</h3>
        <p>Stepping Stones Triple P — a positive parenting program adapted for parents of children with disabilities — has strong evidence for reducing parenting stress and child behavior problems. Family therapy, parent support groups, and sibling programs are important components of comprehensive CP care.</p>
      </div>
      <div class="card green">
        <div class="card-icon"><iconify-icon icon="mdi:heart-pulse"></iconify-icon></div>
        <h3>Biofeedback</h3>
        <p>Biofeedback training helps people with CP learn to regulate physiological signals (muscle tension, heart rate variability) associated with spasticity and pain. EMG biofeedback can improve motor control in specific muscle groups. Heart rate variability biofeedback reduces anxiety and stress responses.</p>
      </div>
      <div class="card orange">
        <div class="card-icon"><iconify-icon icon="mdi:account-group"></iconify-icon></div>
        <h3>Peer Support Programs</h3>
        <p>Peer mentoring — connecting people with CP to others who share similar experiences — is one of the most impactful and underutilized supports. Organizations like Cerebral Palsy Alliance and United Cerebral Palsy run peer networks. Online communities provide 24/7 connection across time zones.</p>
      </div>
    </div>
  </section>

  <!-- INTERNATIONAL RESOURCES -->
  <section id="international" class="section fade-in">
    <div class="section-header">
      <div class="sec-icon"><iconify-icon icon="mdi:earth"></iconify-icon></div>
      <div><h2>Global Resources &amp; International Organizations</h2><p>Worldwide CP support, research, and advocacy</p></div>
    </div>

    <div class="info-box success">
      <h4>CP Affects Every Country</h4>
      <p>Cerebral palsy affects people in every country and across all socioeconomic backgrounds. A strong global network of organizations, research centers, and advocacy groups works to improve care, fund research, and protect the rights of people with CP worldwide.</p>
    </div>

    <div class="cards-grid">
      <div class="card">
        <div class="card-icon"><iconify-icon icon="mdi:account-group"></iconify-icon></div>
        <h3>International Organizations</h3>
        <p>
          <strong>Cerebral Palsy Alliance</strong> — cpalliance.net (Australia, global)<br>
          <strong>United Cerebral Palsy (UCP)</strong> — ucp.org (US)<br>
          <strong>CP Alliance Research Institute (CPARI)</strong> — cpari.org.au<br>
          <strong>Cerebral Palsy Research Network (CPRN)</strong> — cprn.org<br>
          <strong>AACPDM</strong> — aacpdm.org (American Academy for CP and Developmental Medicine)<br>
          <strong>CanChild</strong> — canchild.ca (Canada)<br>
          <strong>European Academy of Childhood Disability (EACD)</strong> — eacd.eu<br>
          <strong>World CP Day</strong> — worldcpday.org — annual awareness day, October 6
        </p>
      </div>
      <div class="card green">
        <div class="card-icon"><iconify-icon icon="mdi:hospital-building"></iconify-icon></div>
        <h3>Leading International CP Centers</h3>
        <p>
          <strong>Kennedy Krieger Institute</strong> — Baltimore, USA — comprehensive CP care, SDR, gait lab<br>
          <strong>Nationwide Children's Hospital</strong> — Columbus, USA — CP program, cord blood trials<br>
          <strong>Holland Bloorview Kids Rehab</strong> — Toronto, Canada — pediatric rehab research<br>
          <strong>Cerebral Palsy Alliance Research Institute</strong> — Sydney, Australia<br>
          <strong>Queen Silvia Children's Hospital</strong> — Gothenburg, Sweden — CPUP registry, SDR<br>
          <strong>Gillette Children's Specialty Healthcare</strong> — Minneapolis, USA — gait analysis, SDR
        </p>
      </div>
      <div class="card orange">
        <div class="card-icon"><iconify-icon icon="mdi:scale-balance"></iconify-icon></div>
        <h3>International Rights &amp; Legal Frameworks</h3>
        <p>
          <strong>UN CRPD</strong> — UN Convention on the Rights of Persons with Disabilities (ratified by 185 countries)<br>
          <strong>IDEA</strong> — Individuals with Disabilities Education Act (US) — free, appropriate public education<br>
          <strong>ADA</strong> — Americans with Disabilities Act — employment, access<br>
          <strong>UK Equality Act 2010</strong> — disability rights in employment and education<br>
          <strong>EU Disability Strategy 2021–2030</strong> — accessibility, inclusion across EU<br>
          <strong>NDIS</strong> — National Disability Insurance Scheme (Australia) — funding support
        </p>
      </div>
    </div>

    <div class="info-box">
      <h4>CPUP — The Swedish CP Registry Model</h4>
      <p>Sweden's CPUP (Cerebral Palsy Follow-up Program) is a national health surveillance program that monitors all children with CP from an early age, screening for hip dislocation, scoliosis, contractures, and other complications. CPUP has nearly eliminated severe hip dislocation in Sweden through proactive monitoring and early intervention. Similar registry programs are being implemented worldwide — including CP-Reg in Australia, SCPE in Europe, and CPNZ in New Zealand.</p>
    </div>
  </section>

  <!-- EMERGENCY -->
  <section id="emergency" class="section fade-in">
    <div class="section-header">
      <div class="sec-icon"><iconify-icon icon="mdi:alarm-light"></iconify-icon></div>
      <div><h2>Emergency Protocols</h2><p>When to call emergency services and how to respond</p></div>
    </div>
    <div class="info-box warning">
      <h4>In Any Life-Threatening Emergency: Call Your Local Emergency Number</h4>
      <p>Emergency numbers by country: <strong>USA &amp; Canada: 911</strong> | <strong>UK: 999</strong> | <strong>Australia &amp; New Zealand: 000</strong> | <strong>Europe (most countries): 112</strong> | <strong>International SOS: 112 (GSM)</strong>. Ensure you have a medical alert document (with CP diagnosis, medications, communication needs, emergency contacts) accessible at all times.</p>
    </div>
    <div class="cards-grid">
      <div class="card">
        <div class="card-icon"><iconify-icon icon="mdi:brain"></iconify-icon></div>
        <h3>Seizure Emergency Protocol</h3>
        <p><strong>Do:</strong> Lay the person on their side (recovery position), protect from injury, time the seizure, stay calm. <strong>Do not:</strong> Restrain, put anything in the mouth, give food or water. <strong>Call emergency services if:</strong> Seizure lasts more than 5 minutes, does not recover normally, injury occurs, or this is a first seizure. <strong>Rescue medication:</strong> Use prescribed rescue medication (rectal diazepam, nasal midazolam, diazepam nasal spray) if seizure exceeds prescribed threshold time.</p>
      </div>
      <div class="card green">
        <div class="card-icon"><iconify-icon icon="mdi:lungs"></iconify-icon></div>
        <h3>Respiratory Distress</h3>
        <p><strong>Signs:</strong> Labored breathing, blue lips or fingernails, gasping, choking, loss of consciousness. <strong>Immediate action:</strong> Call emergency services (911/999/112). If secretion management device is used (CoughAssist, suction machine), use immediately per protocol. Ensure airway is clear. Begin CPR if trained and if no pulse/breathing present. For ventilator-dependent patients — follow your individualized emergency ventilation protocol.</p>
      </div>
      <div class="card orange">
        <div class="card-icon"><iconify-icon icon="mdi:food-off"></iconify-icon></div>
        <h3>Aspiration Emergency</h3>
        <p>Signs of aspiration (inhaling food or liquid into airway): sudden coughing, choking, color change, respiratory distress during or after eating. <strong>Immediate:</strong> Stop feeding, sit upright, apply back blows if choking protocol applies. If unconscious: call emergency services. Aspiration pneumonia requires medical attention — fever, increased respiratory rate, or chest discomfort after a feeding incident warrants urgent medical review.</p>
      </div>
    </div>
    <div class="info-box">
      <h4>Medical Alert Card — Always Carry</h4>
      <p>Create a medical alert document that includes: diagnosis and GMFCS level, communication method, current medications and doses, allergies, known seizure types and rescue medication protocol, ventilator/feeding tube information (if applicable), emergency contacts, and preferred hospital. Keep a copy in the wheelchair bag, backpack, and with school/caregivers.</p>
    </div>
  </section>

  <!-- STORIES -->
  <section id="stories" class="section fade-in">
    <div class="section-header">
      <div class="sec-icon"><iconify-icon icon="mdi:account-voice"></iconify-icon></div>
      <div><h2>Stories of Achievement</h2><p>People with CP who changed the world</p></div>
    </div>
    <div class="cards-grid">
      <div class="card">
        <div class="card-icon"><iconify-icon icon="mdi:book"></iconify-icon></div>
        <h3>Christy Brown (1932–1981)</h3>
        <p>Irish author and painter with spastic quadriplegia, who learned to write and paint using only his left foot. His autobiography "My Left Foot" (1954) became an Oscar-winning film. Christy Brown's life challenged every assumption about cognitive and creative potential in people with severe physical disability. His story remains one of the most powerful in disability history.</p>
      </div>
      <div class="card green">
        <div class="card-icon"><iconify-icon icon="mdi:television"></iconify-icon></div>
        <h3>RJ Mitte</h3>
        <p>Actor known for playing Walt Jr. in Breaking Bad, RJ Mitte has mild CP. He has been a prominent advocate for disability awareness in Hollywood, demonstrating that disability does not limit a career in the entertainment industry. He advocates for authentic casting and representation of people with disabilities on screen.</p>
      </div>
      <div class="card orange">
        <div class="card-icon"><iconify-icon icon="mdi:microphone"></iconify-icon></div>
        <h3>Maysoon Zayid</h3>
        <p>American comedian, actress, and disability advocate with CP. Her TED Talk "I got 99 problems… palsy is just one" is one of the most watched TED Talks on disability — viewed over 16 million times. She co-founded the New York Arab-American Comedy Festival and campaigns for disability representation in media.</p>
      </div>
    </div>
    <div class="cards-grid">
      <div class="card">
        <div class="card-icon"><iconify-icon icon="mdi:run"></iconify-icon></div>
        <h3>Justin Gallegos</h3>
        <p>Justin has CP and became the first athlete with CP to sign a professional contract with Nike. He ran the New York City Marathon and advocates for inclusive athletics. His story is a powerful example of athletic achievement and corporate inclusion in sport.</p>
      </div>
      <div class="card green">
        <div class="card-icon"><iconify-icon icon="mdi:car-sport"></iconify-icon></div>
        <h3>Nicolas Hamilton</h3>
        <p>British racing driver with spastic diplegia CP who competes at the professional level in touring car racing alongside his brother Lewis Hamilton (Formula 1 World Champion). Nicolas has been a prominent advocate for disability in motorsport and demonstrates that spasticity does not preclude high-performance athletics.</p>
      </div>
      <div class="card orange">
        <div class="card-icon"><iconify-icon icon="mdi:trophy"></iconify-icon></div>
        <h3>Josh Blue</h3>
        <p>American comedian and Paralympic soccer player with CP who won the NBC television competition "Last Comic Standing" in 2006. Josh uses humor to challenge perceptions of disability, inspire audiences worldwide, and demonstrate that people with CP can excel in competitive athletics and entertainment simultaneously.</p>
      </div>
    </div>
    <div class="info-box success">
      <h4>World CP Day — October 6</h4>
      <p>World CP Day (worldcpday.org) is an annual global movement that unites people with CP, families, caregivers, researchers, and supporters in over 75 countries. The day raises awareness, celebrates achievements, and drives advocacy for the 17 million people worldwide living with cerebral palsy. Share your story at #WorldCPDay.</p>
    </div>
  </section>

  <!-- RESOURCES -->
  <section id="resources" class="section fade-in">
    <div class="section-header">
      <div class="sec-icon"><iconify-icon icon="mdi:link"></iconify-icon></div>
      <div><h2>Resources</h2><p>Organizations, databases, apps, and books</p></div>
    </div>
    <div class="cards-grid">
      <div class="card">
        <div class="card-icon"><iconify-icon icon="mdi:account-group"></iconify-icon></div>
        <h3>Key Organizations</h3>
        <p>
          <strong>United Cerebral Palsy (UCP)</strong> — ucp.org<br>
          <strong>Cerebral Palsy Foundation (CPF)</strong> — yourcpf.org<br>
          <strong>CPARF</strong> — cparf.org<br>
          <strong>Cerebral Palsy Research Network</strong> — cprn.org<br>
          <strong>AACPDM</strong> — aacpdm.org<br>
          <strong>CanChild</strong> — canchild.ca<br>
          <strong>Cerebral Palsy Alliance</strong> — cpalliance.net
        </p>
      </div>
      <div class="card green">
        <div class="card-icon"><iconify-icon icon="mdi:database"></iconify-icon></div>
        <h3>Research Databases</h3>
        <p>
          <strong>ClinicalTrials.gov</strong> — Search: "Cerebral Palsy"<br>
          <strong>CPARG</strong> — Cerebral Palsy Alliance Research Group<br>
          <strong>Cochrane Cerebral Palsy Group</strong> — cochrane.org<br>
          <strong>PubMed / NCBI</strong> — ncbi.nlm.nih.gov<br>
          <strong>CPNZ Registry</strong> — New Zealand CP registry<br>
          <strong>SCPE</strong> — Surveillance of CP in Europe
        </p>
      </div>
      <div class="card orange">
        <div class="card-icon"><iconify-icon icon="mdi:tablet"></iconify-icon></div>
        <h3>Apps &amp; Tools</h3>
        <p>
          <strong>Proloquo2Go</strong> — AAC communication (iOS)<br>
          <strong>TD Snap</strong> — Tobii Dynavox AAC<br>
          <strong>TouchChat HD</strong> — AAC app<br>
          <strong>Pain DETECT / PainSCAN</strong> — pain assessment<br>
          <strong>AbleLink technologies</strong> — cognitive support apps<br>
          <strong>7 Cups</strong> — online emotional support
        </p>
      </div>
    </div>
    <div class="cards-grid">
      <div class="card">
        <div class="card-icon"><iconify-icon icon="mdi:book-open"></iconify-icon></div>
        <h3>Books</h3>
        <p>
          <em>"My Left Foot"</em> — Christy Brown (autobiography)<br>
          <em>"Disability Studies: Key Concepts"</em> — Rachel Adams<br>
          <em>"The Cerebral Palsy Handbook"</em> — Marion Stanton<br>
          <em>"A Good Life for Your Child with Cerebral Palsy"</em> — Joanna Bernstein<br>
          <em>"Far from the Tree"</em> — Andrew Solomon (chapter on disability)<br>
          <em>"No More Peanut Butter"</em> (for children) — Karen Klenner
        </p>
      </div>
    </div>
  </section>

  <!-- CTA -->
  <div class="carepedia-cta">
    <h3>Was this information helpful?</h3>
    <p>CarePedia is a free resource for rare disease and disability communities. We update our portals regularly with the latest research and treatments.</p>
    <a href="https://carepedia.org" class="cta-btn"><iconify-icon icon="mdi:home"></iconify-icon> Back to CarePedia Home</a>
  </div>

  <footer class="footer">
    <div class="credit-bar">
      <span>CarePedia Cerebral Palsy Hub &copy; 2025</span>
      <span>|</span>
      <span>Information updated regularly. Always consult your medical team.</span>
      <a href="https://carepedia.org/request" class="portal-request-btn"><iconify-icon icon="mdi:plus-circle"></iconify-icon> Request a Disease Portal</a>
    </div>
  </footer>

</main>

<button class="scroll-top" id="scrollTop" onclick="window.scrollTo({top:0,behavior:'smooth'})">
  <iconify-icon icon="mdi:chevron-up"></iconify-icon>
</button>

<script>
function toggleMenu() {
  const sidebar = document.getElementById('sidebar');
  const toggle = document.getElementById('menuToggle');
  const overlay = document.getElementById('overlay');
  sidebar.classList.toggle('open');
  toggle.classList.toggle('open');
  overlay.classList.toggle('active');
}
function closeMenu() {
  document.getElementById('sidebar').classList.remove('open');
  document.getElementById('menuToggle').classList.remove('open');
  document.getElementById('overlay').classList.remove('active');
}
function navigateTo(id) {
  closeMenu();
  const el = document.getElementById(id);
  if (el) el.scrollIntoView({ behavior: 'smooth' });
  document.querySelectorAll('.sidebar nav a').forEach(a => a.classList.remove('active'));
  const link = document.querySelector('.sidebar nav a[href="#' + id + '"]');
  if (link) link.classList.add('active');
}
function toggleAccordion(header) {
  const body = header.nextElementSibling;
  const isOpen = header.classList.contains('open');
  document.querySelectorAll('.accordion-header.open').forEach(h => {
    h.classList.remove('open');
    h.nextElementSibling.style.maxHeight = '0';
  });
  if (!isOpen) {
    header.classList.add('open');
    body.style.maxHeight = body.scrollHeight + 'px';
  }
}
function switchTab(btn, tabId) {
  const section = btn.closest('section') || btn.closest('.section') || btn.parentElement.parentElement;
  section.querySelectorAll('.tab-btn').forEach(b => b.classList.remove('active'));
  section.querySelectorAll('.tab-content').forEach(c => c.classList.remove('active'));
  btn.classList.add('active');
  const target = document.getElementById(tabId);
  if (target) target.classList.add('active');
}

// Scroll progress bar
window.addEventListener('scroll', () => {
  const scrolled = window.scrollY;
  const total = document.body.scrollHeight - window.innerHeight;
  document.getElementById('scrollBar').style.width = (scrolled / total * 100) + '%';
  document.getElementById('scrollTop').classList.toggle('visible', scrolled > 400);
  // Update active nav link
  const sections = document.querySelectorAll('section[id], div.section[id]');
  let current = '';
  sections.forEach(sec => {
    if (window.scrollY >= sec.offsetTop - 200) current = sec.id;
  });
  document.querySelectorAll('.sidebar nav a').forEach(a => {
    a.classList.toggle('active', a.getAttribute('href') === '#' + current);
  });
});

// Fade-in observer
const observer = new IntersectionObserver(entries => {
  entries.forEach(e => { if (e.isIntersecting) e.target.classList.add('visible'); });
}, { threshold: 0.1 });
document.querySelectorAll('.fade-in').forEach(el => observer.observe(el));
</script>
</body>
</html>
